Patent: 9,498,481
✉ Email this page to a colleague
Summary for Patent: 9,498,481
Title: | Cyclopropyl modulators of P2Y12 receptor |
Abstract: | The present invention relates to new cyclopropyl modulators of P2Y12 receptor activity, pharmaceutical compositions thereof, and methods of use thereof. ##STR00001## |
Inventor(s): | Rao; Tadimeti (San Diego, CA), Zhang; Chengzhi (San Diego, CA) |
Assignee: | Auspex Pharmaceuticals, Inc. (LaJolla, CA) |
Application Number: | 14/977,056 |
Patent Claims: | see list of patent claims |
Details for Patent 9,498,481
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bausch Health Us, Llc | IPRIVASK | desirudin | For Injection | 021271 | 04/04/2003 | ⤷ Try a Trial | 2029-07-27 |
Microbix Biosystems Inc. | KINLYTIC | urokinase | For Injection | 021846 | 01/16/1978 | ⤷ Try a Trial | 2029-07-27 |
Genentech, Inc. | ACTIVASE | alteplase | For Injection | 103172 | 11/13/1987 | ⤷ Try a Trial | 2029-07-27 |
Genentech, Inc. | CATHFLO ACTIVASE | alteplase | For Injection | 103172 | 09/04/2001 | ⤷ Try a Trial | 2029-07-27 |
Janssen Biotech, Inc. | REOPRO | abciximab | Injection | 103575 | 12/22/1994 | ⤷ Try a Trial | 2029-07-27 |
Chiesi Usa, Inc. | RETAVASE | reteplase | For Injection | 103786 | 10/30/1996 | ⤷ Try a Trial | 2029-07-27 |
Genentech, Inc. | TNKASE | tenecteplase | For Injection | 103909 | 06/02/2000 | ⤷ Try a Trial | 2029-07-27 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |